Clinical Trial Update: Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes the combination of vorinostat and lenalidomide in patients with relapsed or refractory Hodgkin lymphoma or non-Hodgkin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)
• Vorinostat (Zolinza) (vorinostat)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Status: TERMINATED